bioRxiv / medRxivopen access
Combining VEGFR tyrosine kinase inhibitors and PD-1/PD-L1 inhibitors versus VEGFR tyrosine kinase inhibitors monotherapy in renal cell carcinoma: a target trial emulation
health informatics
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 417388
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.